Crossmark

Treatment with 48-mm everolimus-eluting stents

Crossref DOI link: https://doi.org/10.1007/s00059-017-4670-2

Published Online: 2018-01-16

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tan, C. K.

Tin, Z. L.

Arshad, M. K. M.

Loh, J. K. K.

Jafary, F. H.

Ho, H. H.

Ong, P. J. L.

Watson, T.
License Information

Text and Data Mining valid from 2018-01-16
More Information

Article History

Received: 9 October 2017

Revised: 11 November 2017

Accepted: 4 December 2017

First Online: 16 January 2018

Compliance with ethical guidelines

:

: C.K. Tan, Z.L. Tin, M.K.M. Arshad, J.K.K. Loh, F.H. Jafary, H.H. Ho, P.J.L. Ong, and T. Watson declare that they have no competing interests.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.